De EMCDDA heeft een aan dit onderwerp gewijd document gepubliceerd onder de titel „GHB and its precursor GBL: an emerging trend case study” waarin wordt gesteld dat de GHB-stof „has a steep dose-response curve where even a small increase in dose can cause serious toxic effects, including impaired consciousness and coma”.
The European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) has published a document entitled ‘GHB and its precursor GBL: an emerging trend case study’ which states that the drug ‘has a steep dose-response curve where even a small increase in dose can cause serious toxic effects, including impaired consciousness and coma’.not-set not-set